Next Generation News and Research

RSS

miRagen and CU enter agreement on miRNA therapeutics discovery and development

miRagen Therapeutics, Inc., a biopharmaceutical company focused on improving patients' lives by developing innovative microRNA (miRNA)-based therapeutics for cardiovascular and muscle disease, and the University of Colorado (CU) announced today that they have entered into sponsored research and licensing agreements to collaborate on miRNA therapeutics discovery and development.

26 Oct 2010

Helicos names Illumina and Life Technologies as additional defendants in lawsuit against Pacific Biosciences

Helicos BioSciences Corporation announced today that it has amended its lawsuit against Pacific Biosciences of California, Inc. for patent infringement by naming Illumina, Inc. and Life Technologies Corporation as additional defendants.

From Illumina, Inc. 25 Oct 2010

VitalHealth and Mayo Medical Laboratories collaborate to offer EHR

VitalHealth (MGMA Booth #1560) and Mayo Medical Laboratories have entered into a collaboration to offer VitalHealth's Electronic Health Record (EHR) product, including a solution for physician office connectivity, as part of Mayo Medical Laboratories' outreach offering.

25 Oct 2010

GSN initiates trial of microarray PGD on pregnancy and implantation rates in IVF

Gene Security Network (GSN) announced today that it has initiated enrollment for a prospective randomized trial in collaboration with Ferring Pharmaceuticals to evaluate the impact of GSN's advanced preimplantation genetic diagnosis (PGD) with Parental Support™ on pregnancy and implantation rates in IVF.

25 Oct 2010

Canon to showcase imageFORMULA document scanning portfolio at MGMA Annual Conference

Reflecting the increased need for medical practices and healthcare facilities to streamline patient record processes in order to increase efficiency across a range of insurance and billing functions, Canon U.S.A., Inc., a leader in digital imaging, will showcase an array of workflow simplifying solutions from its innovative imageFORMULA document scanning portfolio, including the new ScanFront 300P network scanner, at the Medical Group Management Association (MGMA) 2010 Annual Conference, October 24-27, 2010 at the Ernest N. Morial Convention Center in New Orleans.

25 Oct 2010

Inovio announces publication of minimally-invasive intradermal device in journal Gene Therapy

Inovio Pharmaceuticals, Inc. a leader in the development of therapeutic and preventive vaccines against cancers and infectious diseases, announced today that a peer-reviewed research article describing the development of a new intradermal, minimally-invasive DNA vaccine delivery device was published in the prestigious journal Gene Therapy.

25 Oct 2010

ISTSS to honor Vietnam veteran with Lifetime Achievement Award

Joseph Boscarino, Ph.D, M.P.H.,will be recognized by the International Society of Traumatic Stress (ISTSS) with a Lifetime Achievement Award for his contributions to the research of traumatic stress.

25 Oct 2010

LifeGen Technologies awarded Phase I Small Business Innovative Research grant

LifeGen Technologies, LLC has been awarded a Phase I Small Business Innovative Research grant from the United States National Institute on Aging. The project is focused on identifying a robust panel of genes in adipose tissue (fat) that are regulated by a calorie restricted diet. According to Dr. Jamie Barger, Director of Operations at LifeGen, the technology developed under the NIH grant will allow LifeGen to screen for compounds that have beneficial effects on adipose tissue in a manner similar to that of a calorie restricted diet.

22 Oct 2010

Biogen, Genentech announce new structure of anti-CD20 collaboration

Biogen Idec and Genentech, Inc. a wholly owned member of the Roche Group today announced that they have agreed to amend their collaboration on antibodies targeting CD20.

22 Oct 2010

Orthopaedic Surgeon implants first MIDLINE device at Valley Hospital

Just days after Centinel Spine's new STALIF MIDLINE Integrated Interbody Fusion system was unveiled at the annual meeting of the North American Spine Society (NASS), the first MIDLINE device has been successfully implanted by noted Orthopaedic Surgeon, John S. Thalgott, MD at Valley Hospital in Las Vegas, NV.

22 Oct 2010

Dicerna secures $4 million in second closing of Series B equity financing

Dicerna Pharmaceuticals, Inc. a second generation RNA interference (RNAi) company developing novel therapeutics utilizing its proprietary Dicer Substrate Technology and Dicer Substrate siRNA (DsiRNA) molecules, today announced a second closing of its Series B equity financing, securing an additional $4 million and bringing the total capital raised in this round to $29 million.

22 Oct 2010

DynaVox releases new additions to Vmax line of communication devices

DynaVox, the leading provider of speech generating devices and symbol-adapted special education software used to assist individuals in overcoming speech, language and learning challenges, today announced the release of two new additions to the Vmax™ line of communication devices, the Vmax+ High Performance and the Vmax+ Battery Efficiency.

21 Oct 2010

Researchers investigate reverse zoonosis in marine invertebrate

The spread of lethal diseases from animals to humans has long been an issue of great concern to public health officials. But what about diseases that spread in the other direction, from humans to wildlife. A multidisciplinary team of researchers at the University of Georgia has just been awarded a five-year $2 million Ecology of Infectious Diseases grant from the National Science Foundation and National Institutes of Health to study the first known case of such a "reverse zoonosis" that involves the transmission of a human pathogen to a marine invertebrate, elkhorn coral.

21 Oct 2010

Intercell and Romark announce IC41-nitazoxanide combination clinical trials for HCV

Intercell AG and Romark Laboratories L.C. today announced plans to commence clinical trials of Intercell's investigational therapeutic Hepatitis C virus (HCV) vaccine, IC41, in combination with Romark's antiviral drug, nitazoxanide, during the first half of 2011.

21 Oct 2010

LSUHSC receives NIH grant for research on cancer and infectious diseases

LSU Health Sciences Center New Orleans has been awarded $12 million over five years by the National Institutes of Health to conduct research on diseases like prostate and stomach cancers, lymphoma and leukemia, dengue fever, tuberculosis, and herpes infections, as well as to support the development of academic research scientists.

21 Oct 2010

New mechanism controlling transmission of abnormal signal at origin of several cancers identified

Researchers at the Institute for Research in Immunology and Cancer (IRIC) of the Universit- de Montr-al have identified a new mechanism controlling the transmission of an abnormal signal at the origin of several cancers. In an article published in the journal Cell, Marc Therrien's team explains the recent discovery of a protein complex that controls the RAS/MAPK signalling pathway, responsible for some of the deadliest cancers, including pancreatic, colon and lung cancers, and melanomas.

21 Oct 2010

New immunoSEQ bioinformatics software platform helps monitor adaptive immune system

Adaptive TCR Technologies, a biotech firm based in Seattle, WA, announced today the release of its immunoSEQ profiling service and immunoSEQ Analyzer bioinformatics software platform. Together, these tools provide researchers and clinicians the ability to profile and monitor the adaptive immune system at a level of detail that has never before been possible.

21 Oct 2010

FDA purchases AB SCIEX QTRAP 5500 Systems for analysis of the U.S. food supply

AB SCIEX, a global leader in life science analytical technologies, today announced that the U.S. Food and Drug Administration has purchased eight of the company's AB SCIEX QTRAP® 5500 Systems for analysis of the U.S. food supply. These mass spectrometry systems will be deployed at FDA headquarters and across seven field laboratories. This supports government initiatives to help ensure food safety.

20 Oct 2010

Abbott third quarter worldwide sales increase 11.8% to $8.7 billion

Abbott today announced financial results for the third quarter ended Sept. 30, 2010.

20 Oct 2010

New model for rural clinics in underserved areas

The University of Maryland Dental School Clinic, Perryville is a new model for rural clinics in underserved areas across the country, says Christian S. Stohler, DMD, DrMedDent, dean of the Dental School in Baltimore.

20 Oct 2010